98 related articles for article (PubMed ID: 1333368)
1. The importance of schedule on diethyldithiocarbamate modulation of drug-induced myelosuppression.
East CJ; Borch RF
Cancer Chemother Pharmacol; 1992; 31(2):123-6. PubMed ID: 1333368
[TBL] [Abstract][Full Text] [Related]
2. Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II).
Gringeri A; Keng PC; Borch RF
Cancer Res; 1988 Oct; 48(20):5708-12. PubMed ID: 2844391
[TBL] [Abstract][Full Text] [Related]
3. Diethyldithiocarbamate modulation of murine bone marrow toxicity induced by cis-diammine(cyclobutanedicarboxylato)platinum (II).
Schmalbach TK; Borch RF
Cancer Res; 1989 Dec; 49(23):6629-33. PubMed ID: 2555048
[TBL] [Abstract][Full Text] [Related]
4. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
Schmalbach TK; Borch RF
Cancer Res; 1989 May; 49(10):2574-7. PubMed ID: 2540902
[TBL] [Abstract][Full Text] [Related]
5. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Carfagna PF; Chaney SG; Chang J; Holbrook DJ
Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
[TBL] [Abstract][Full Text] [Related]
6. The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.
Dible SE; Siddik ZH; Boxall FE; Harrap KR
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):813-8. PubMed ID: 2820745
[TBL] [Abstract][Full Text] [Related]
7. Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 rats.
Carfagna PF; Wyrick SD; Holbrook DJ; Chaney SG
J Biochem Toxicol; 1991; 6(1):71-80. PubMed ID: 1652641
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of diethyldithiocarbamate modulation of murine bone marrow toxicity.
Schmalbach TK; Borch RF
Cancer Res; 1990 Oct; 50(19):6218-21. PubMed ID: 2169339
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
10. The effect of cytotoxic drugs on the development of murine granulocyte-macrophage (GM) progenitor cells.
Cylwik B; Szmitkowski M
Mater Med Pol; 1992; 24(4):262-5. PubMed ID: 1308058
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.
Ajani JA; Spitzer G; Tomasovic B; Drewinko B; Hug VM; Dicke K
Br J Cancer; 1986 Oct; 54(4):607-13. PubMed ID: 3778805
[TBL] [Abstract][Full Text] [Related]
12. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
13. Potassium oxonate modulation of 5-fluorouracil-induced myelotoxicity in murine and human colony forming assays of hematopoietic precursor cells.
Kouchi Y; Maeda Y; Ohuchida A; Nomura N
Toxicol Lett; 2002 Sep; 135(1-2):11-8. PubMed ID: 12243859
[TBL] [Abstract][Full Text] [Related]
14. Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.
Pannacciulli IM; Lerza RA; Bogliolo GV; Mencoboni MP; Saviane AG
Br J Cancer; 1989 Mar; 59(3):371-4. PubMed ID: 2539178
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
16. The effect of glucocorticoids on the development of murine granulocyte-macrophage (GM) progenitors.
Cylwik B; Szmitkowski M; Chrostek L
Mater Med Pol; 1992; 24(1):14-6. PubMed ID: 1308262
[TBL] [Abstract][Full Text] [Related]
17. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
19. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
20. A novel in vivo model for predicting myelotoxicity of chemotherapeutic agents using IL-3/GM-CSF transgenic humanized mice.
Ito R; Nagai D; Igo N; Okuda Y; Sekine K; Ichimura E; Katano I; Mizushima T; Goto M; Ohnishi Y; Ito M; Okamoto K
Toxicol Lett; 2017 Nov; 281():152-157. PubMed ID: 28947270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
